ASAIO Journal · 5 Nov 2026
Current Global Trends and Challenges of Pediatric Ventricular Assist Device Programs: An ACTION Collaborative Survey
Ah Young Kim, Alfred Asante-Korang, HaEun Jazmin Kim, Angela Lorts, Robert A. Niebler, Matthew J. O’Connor, Nikita Orwick, David Rosenthal, Swati Sehgal, David Sutcliffe, Christina VanderPluym, Matthew Zinn, Anna Joongh-index 14
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Ventricular assist devices (VADs) have become an established therapy for children with end-stage heart failure, yet multinational data describing pediatric VAD programs remain limited. We conducted a 12 question survey through the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) involving 74 international healthcare professionals from pediatric VAD programs outside North America. The survey assessed device and resource availability, multidisciplinary team composition, program challenges, and future priorities. Fifteen responses representing 15 centers from 14 countries were received, including 13 centers with established pediatric VAD programs. Most centers (91%, 10/11) managed 1–5 pediatric VAD patients annually. Berlin Heart EXCOR and HeartMate 3 were available in 85% (11/13) of centers, while only 46.7% (7/15) had a dedicated VAD coordinator. Major barriers included inadequate education for intensive care unit (ICU) and nursing staff and patients (69%, 9/13), financial constraints (54%, 7/13), limited device availability (46%, 6/13), and lack of outpatient VAD experience, with 31% (4/13) of centers reporting no experience discharging patients on VAD support. Substantial variation in device availability, multidisciplinary resources, and program experience exists across regions. These findings highlight important gaps in pediatric VAD care and support international collaboration to improve education, infrastructure, and access to advanced heart failure therapies.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Anna Joong has the highest h-index among the authors (14).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (21)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 1 more reference
A free account opens the rest of the citing papers and references on every paper’s page.